产品编号：N900295
产品规格：250mg
产品价格：面议
| 标准品编号: | N900295 |
| 名称: | NSC 379317 |
| 别名: | 4,4'-[[(Carboxymethyl)imino]diethylene]di-(2,6-morpholinedione); N,N-Bis[2-(2,6-dioxo-4-morpholinyl)ethyl]glycine; 1,5-Bis(2,6-dioxomorpholino)-3-azapentane-3-acetic Acid; 2-[Bis[2-(2,6-dioxomorpholino)ethyl]amino]acetic Acid; Cyclic DTPA Anhydride; DTPA Anhydride; DTPA Ayclic Anhydride; DTPA Dianhydride; DTPAA; Diethylenetriamine-N,N,N',N'',N''-pentaacetic Acid N,N''-Dianhydride; Diethylenetriamine-N,N,N',N'',N''-pentacetic Dianhydride; Diethylenetriaminepentaacetic Acid Dianhydride; Diethylenetriaminepentaacetic Bisanhydride; Diethylenetriaminepentaacetic Dianhydride; |
| CAS号: | 23911-26-4 |
| 分子式: | C₁₄H₁₉N₃O₈ |
| 分子量: | 357.32 |
| 储存: | Hygroscopic, 冰箱, under inert atmosphere |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | NSC 379317 or DTPAA is a useful synthetic intermediate in producing DPTA, in which it is used to synthesize the GO-DEN(Gd-DTPA)-mAb, a contrast reagent for prostate tumor MRI imaging. GO-DEN(Gd-DTPA)-mAb can be coupled with DOX to produce GO-DEN(Gd-DTPA)-mAb/DOX, creating an effective delivery of anti cancer drugs to the prostate cancer cells, PC-3, in mice. |
| 参考文献 | |
